Table 1.
Demographics and tumor-related details
| Variable | Modified CROSS (n = 36) |
|---|---|
| Age, years° | 61.3 (11.52) |
| Body mass indexa | 24.7 (21.5–26.4) |
| Gender | |
| Male | 31 (86.1) |
| Female | 5 (13.9) |
| ASA classification | |
| ASA 1 | 4 (11.1) |
| ASA 2 | 19 (52.8) |
| ASA 3 | 13 (36.1) |
| Tumor location | |
| Thoracic | 16 (44.4) |
| Siewert type I | 14 (38.9) |
| Siewert type II | 6 (16.7) |
| Tumor histology, No. (%) | |
| Adenocarcinoma | 20 (55.6) |
| Squamous cell carcinoma | 16 (44.4) |
| Clinical tumor staging | |
| cT2 | 5 (13.9) |
| cT3 | 29 (80.6) |
| cT4a | 2 (5.6) |
| Clinical nodal staging | |
| cN0 | 2 (5.5) |
| cN1 | 34 (94.4) |
| cN2 | 0 |
CROSS neoadjuvant radiochemotherapy; ASA American Society of Anesthesiologists
Values in parentheses are percentages unless indicated otherwise; °values are mean (standard deviation)
avalues are median (interquartile range)